Latest / Seattle News Today | 2 Min News | The Daily News Now!
FDA Peptide Review Sparks Legal Battle | Seattle News
The FDA is reviewing a list of 17 compounded peptides—key amino acid chains that help regulate everything from sleep to inflammation—and could soon restrict their availability, sparking a legal battle from EVEXIAS Life Sciences. Patients relying on these custom treatments for chronic conditions may lose access if the ban sticks. Experts urge caution against unregulated online peptide mixes, warning of contamination and dosage risks. The FDA’s final call could reshape the future of personalized wellness therapies. Listen in comfort:Get a discount on a Soli Pillow…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.